2 scintillating growth stocks you daren’t miss

Royston Wild reveals two stocks with stunning earnings potential.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Shares in Porvair (LSE: PRV), although failing to react to latest trading details, remain locked close to record peaks in Tuesday trade at around 520p per share.

The industrial filter manufacturer has ascended 66% in value during the past 12 months alone, and I believe there is plenty of scope for further stock price strength.

In its latest trading statement Porvair commented today that it has “made a good start to 2017” with sales rising 6% year-on-year, or 7% on an underlying basis. It also described its order books for the remainder of the year as “healthy.”

The company noted that its Aerospace, US industrial and Seal Analytical divisions have all performed well in recent months, and added that “progress towards commissioning large projects continues on track with very little revenue recognised compared with the prior period, as expected.”

It has a long history of creating robust bottom-line growth, and City brokers expect this trend to continue with expansion of 5% and 7% in the years to November 2017 and 2018 respectively.

However, current forecasts make it an expensive pick at first glance, the firm dealing on a prospective P/E ratio of 28.5 times.

Still, I believe the company’s expertise across a broad range of markets, not to mention its wide footprint across developed and emerging economies make it worthy of serious attention. Indeed, Porvair has seen sales in the US and Asia in particular detonate during the past 12 months, and these growth regions now account for 38% and 24% of group sales respectively.

And Porvair bought New Jersey-based JG Finneran Associates — which builds specialist laboratory equipment like filters, vials and microplates — earlier this month for a potential $14m to bolster its Stateside position still further.

A favoured foodie

But it isn’t the only hot growth stock benefitting from an exciting outlook in the US.

Indeed, food manufacturer Greencore (LSE: GNC) saw revenues shoot 17.1% higher during the three months to December, to ÂŁ417m, thanks in no small part to its transatlantic footprint. Sales were also up 9.1% on a like-for-like basis.

At its core Convenience Food division, Greencore saw revenues in the UK and US leap 9% and 8% higher respectively during October-December, and the business is ratcheting up investment on both sides of the Pond to keep sales on an upward trajectory. Construction work at its shiny new manufacturing plant in Northampton has now been completed, while new facilities in Rhode Island and Seattle have boosted Greencore’s position in North America.

And the acquisition of Peacock Foods in December underlines its belief in the US marketplace, a move that should widen the Irish company’s customer base beyond core retail clients and enhance its product ranges.

The number crunchers expect Greencore to keep its own strong growth record going with earnings rises of 3% in the year to September 2017. And a 10% sprint higher is forecast for fiscal 2018.

These forecasts leave it dealing on an attractive P/E ratio of 15.3 times. This is great value for money, in my opinion, given the company’s exciting growth strategy and particularly on foreign shores.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Royston Wild has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended Greencore. The Motley Fool UK owns shares of Porvair. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »